nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ADORA1—Gabapentin—migraine	0.442	0.669	CbGbCtD
Mefloquine—ABCB1—Timolol—migraine	0.0256	0.0388	CbGbCtD
Mefloquine—CYP2D6—Timolol—migraine	0.0242	0.0366	CbGbCtD
Mefloquine—ABCB1—Propranolol—migraine	0.0229	0.0346	CbGbCtD
Mefloquine—CYP2D6—Propranolol—migraine	0.0215	0.0326	CbGbCtD
Mefloquine—ABCB1—Amitriptyline—migraine	0.0198	0.0299	CbGbCtD
Mefloquine—CYP2D6—Amitriptyline—migraine	0.0186	0.0282	CbGbCtD
Mefloquine—HBA2—Scavenging of heme from plasma—LRP1—migraine	0.0172	0.196	CbGpPWpGaD
Mefloquine—ABCB1—Verapamil—migraine	0.0157	0.0237	CbGbCtD
Mefloquine—CYP2D6—Verapamil—migraine	0.0148	0.0224	CbGbCtD
Mefloquine—CYP3A4—Propranolol—migraine	0.0137	0.0207	CbGbCtD
Mefloquine—HBA1—Scavenging of heme from plasma—LRP1—migraine	0.013	0.148	CbGpPWpGaD
Mefloquine—CYP3A4—Amitriptyline—migraine	0.0118	0.0179	CbGbCtD
Mefloquine—CYP3A4—Valproic Acid—migraine	0.0108	0.0163	CbGbCtD
Mefloquine—CYP3A4—Topiramate—migraine	0.00974	0.0147	CbGbCtD
Mefloquine—CYP3A4—Verapamil—migraine	0.0094	0.0142	CbGbCtD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.00685	0.0781	CbGpPWpGaD
Mefloquine—HBA2—blood vessel—migraine	0.00526	0.0921	CbGeAlD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.00519	0.0592	CbGpPWpGaD
Mefloquine—HBA2—neck—migraine	0.00376	0.0659	CbGeAlD
Mefloquine—HBA1—brainstem—migraine	0.00313	0.0548	CbGeAlD
Mefloquine—ADORA1—nerve—migraine	0.00301	0.0527	CbGeAlD
Mefloquine—HBA1—cardiovascular system—migraine	0.00256	0.0448	CbGeAlD
Mefloquine—HBA2—cardiovascular system—migraine	0.00235	0.0411	CbGeAlD
Mefloquine—HBA1—Vitamin B12 Metabolism—MTHFR—migraine	0.00184	0.021	CbGpPWpGaD
Mefloquine—HBA1—head—migraine	0.00173	0.0303	CbGeAlD
Mefloquine—HBA1—nervous system—migraine	0.00164	0.0287	CbGeAlD
Mefloquine—HBA2—head—migraine	0.00159	0.0278	CbGeAlD
Mefloquine—HBA1—central nervous system—migraine	0.00158	0.0277	CbGeAlD
Mefloquine—HBA1—cerebellum—migraine	0.00154	0.027	CbGeAlD
Mefloquine—HBA2—nervous system—migraine	0.00151	0.0264	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—MTHFR—migraine	0.0015	0.017	CbGpPWpGaD
Mefloquine—ADORA1—trigeminal ganglion—migraine	0.00146	0.0256	CbGeAlD
Mefloquine—ACHE—trigeminal ganglion—migraine	0.00145	0.0254	CbGeAlD
Mefloquine—HBA2—central nervous system—migraine	0.00145	0.0254	CbGeAlD
Mefloquine—HBA2—cerebellum—migraine	0.00142	0.0248	CbGeAlD
Mefloquine—HBA1—brain—migraine	0.00125	0.022	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—migraine	0.00122	0.0214	CbGeAlD
Mefloquine—HBA1—Selenium Micronutrient Network—MTHFR—migraine	0.00119	0.0135	CbGpPWpGaD
Mefloquine—HBA2—brain—migraine	0.00115	0.0202	CbGeAlD
Mefloquine—ADORA2A—Monoamine Transport—SLC6A4—migraine	0.0011	0.0125	CbGpPWpGaD
Mefloquine—ADORA1—cardiovascular system—migraine	0.00105	0.0185	CbGeAlD
Mefloquine—ADORA2A—G alpha (s) signalling events—RAMP1—migraine	0.000906	0.0103	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—CALCRL—migraine	0.000906	0.0103	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—SLC6A4—migraine	0.000875	0.00998	CbGpPWpGaD
Mefloquine—ADORA2A—head—migraine	0.000827	0.0145	CbGeAlD
Mefloquine—CYP19A1—Ovarian Infertility Genes—PGR—migraine	0.00082	0.00935	CbGpPWpGaD
Mefloquine—HBA1—Vitamin B12 Metabolism—TNF—migraine	0.000791	0.00902	CbGpPWpGaD
Mefloquine—ADORA2A—nervous system—migraine	0.000784	0.0137	CbGeAlD
Mefloquine—ADORA2A—central nervous system—migraine	0.000755	0.0132	CbGeAlD
Mefloquine—ADORA2A—cerebellum—migraine	0.000738	0.0129	CbGeAlD
Mefloquine—ADORA1—head—migraine	0.000714	0.0125	CbGeAlD
Mefloquine—BCHE—trigeminal ganglion—migraine	0.000713	0.0125	CbGeAlD
Mefloquine—ADORA1—nervous system—migraine	0.000677	0.0119	CbGeAlD
Mefloquine—CYP19A1—FSH signaling pathway—BDNF—migraine	0.000669	0.00763	CbGpPWpGaD
Mefloquine—ADORA1—central nervous system—migraine	0.000652	0.0114	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—TNF—migraine	0.000644	0.00734	CbGpPWpGaD
Mefloquine—ADORA1—cerebellum—migraine	0.000637	0.0112	CbGeAlD
Mefloquine—ACHE—cerebellum—migraine	0.000633	0.0111	CbGeAlD
Mefloquine—BCHE—brainstem—migraine	0.000631	0.0111	CbGeAlD
Mefloquine—ADORA2A—brain—migraine	0.000599	0.0105	CbGeAlD
Mefloquine—ACHE—Neuronal System—KCNK18—migraine	0.000587	0.00669	CbGpPWpGaD
Mefloquine—ABCB1—blood vessel—migraine	0.00055	0.00964	CbGeAlD
Mefloquine—BCHE—Neuronal System—KCNK18—migraine	0.000524	0.00597	CbGpPWpGaD
Mefloquine—ADORA1—brain—migraine	0.000517	0.00906	CbGeAlD
Mefloquine—BCHE—cardiovascular system—migraine	0.000515	0.00902	CbGeAlD
Mefloquine—ACHE—brain—migraine	0.000514	0.00901	CbGeAlD
Mefloquine—HBA1—Selenium Micronutrient Network—TNF—migraine	0.000511	0.00583	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—HTR1D—migraine	0.000511	0.00583	CbGpPWpGaD
Mefloquine—CYP19A1—head—migraine	0.000484	0.00848	CbGeAlD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000474	0.00541	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CACNA1A—migraine	0.000474	0.0054	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—EDNRA—migraine	0.000462	0.00527	CbGpPWpGaD
Mefloquine—CYP19A1—nervous system—migraine	0.000459	0.00804	CbGeAlD
Mefloquine—CYP19A1—central nervous system—migraine	0.000442	0.00774	CbGeAlD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000441	0.00503	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—RAMP1—migraine	0.000426	0.00486	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CALCRL—migraine	0.000426	0.00486	CbGpPWpGaD
Mefloquine—CYP2D6—brainstem—migraine	0.000418	0.00732	CbGeAlD
Mefloquine—ADORA2A—GPCRs, Other—HTR7—migraine	0.000416	0.00474	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000406	0.00463	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—NPS—migraine	0.000378	0.00431	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000378	0.00431	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000374	0.00427	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—ACE—migraine	0.000368	0.00419	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000366	0.00418	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CACNA1A—migraine	0.000359	0.0041	CbGpPWpGaD
Mefloquine—CYP19A1—brain—migraine	0.000351	0.00615	CbGeAlD
Mefloquine—BCHE—head—migraine	0.000349	0.00611	CbGeAlD
Mefloquine—ADORA2A—G alpha (s) signalling events—CALCA—migraine	0.000347	0.00396	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000341	0.00388	CbGpPWpGaD
Mefloquine—ABCB1—trigeminal ganglion—migraine	0.00034	0.00595	CbGeAlD
Mefloquine—BCHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000334	0.00381	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NPS—migraine	0.000333	0.00379	CbGpPWpGaD
Mefloquine—BCHE—nervous system—migraine	0.000331	0.00579	CbGeAlD
Mefloquine—ADORA2A—GPCR ligand binding—RAMP1—migraine	0.000329	0.00375	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CALCRL—migraine	0.000329	0.00375	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—ACE—migraine	0.000328	0.00374	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—SLC6A4—migraine	0.000326	0.00372	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—HTR7—migraine	0.000325	0.0037	CbGpPWpGaD
Mefloquine—BCHE—central nervous system—migraine	0.000318	0.00558	CbGeAlD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000314	0.00358	CbGpPWpGaD
Mefloquine—BCHE—cerebellum—migraine	0.000311	0.00545	CbGeAlD
Mefloquine—ADORA1—G alpha (i) signalling events—HTR1B—migraine	0.00031	0.00353	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR1D—migraine	0.00031	0.00353	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—HTR1A—migraine	0.000298	0.0034	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—ESR1—migraine	0.000292	0.00333	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000292	0.00333	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—HTR2A—migraine	0.000291	0.00332	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—TNF—migraine	0.000289	0.0033	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR2B—migraine	0.000288	0.00328	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000287	0.00328	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—CACNA1A—migraine	0.000287	0.00327	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—HTR7—migraine	0.000286	0.00326	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000277	0.00315	CbGpPWpGaD
Mefloquine—Mediastinal disorder—Timolol—migraine	0.000272	0.00139	CcSEcCtD
Mefloquine—Agitation—Valproic Acid—migraine	0.000271	0.00139	CcSEcCtD
Mefloquine—Visual impairment—Gabapentin—migraine	0.00027	0.00139	CcSEcCtD
Mefloquine—Urticaria—Verapamil—migraine	0.000269	0.00138	CcSEcCtD
Mefloquine—Nausea—Amitriptyline—migraine	0.000269	0.00138	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000267	0.00305	CbGpPWpGaD
Mefloquine—Alopecia—Timolol—migraine	0.000266	0.00137	CcSEcCtD
Mefloquine—Malaise—Valproic Acid—migraine	0.000266	0.00136	CcSEcCtD
Mefloquine—Erythema multiforme—Gabapentin—migraine	0.000265	0.00136	CcSEcCtD
Mefloquine—Vertigo—Valproic Acid—migraine	0.000265	0.00136	CcSEcCtD
Mefloquine—Asthenia—Propranolol—migraine	0.000265	0.00136	CcSEcCtD
Mefloquine—Pneumonia—Topiramate—migraine	0.000264	0.00136	CcSEcCtD
Mefloquine—Mental disorder—Timolol—migraine	0.000264	0.00136	CcSEcCtD
Mefloquine—Leukopenia—Valproic Acid—migraine	0.000264	0.00135	CcSEcCtD
Mefloquine—ACHE—ATF-2 transcription factor network—FOS—migraine	0.000263	0.003	CbGpPWpGaD
Mefloquine—Erythema—Timolol—migraine	0.000262	0.00135	CcSEcCtD
Mefloquine—Malnutrition—Timolol—migraine	0.000262	0.00135	CcSEcCtD
Mefloquine—Eye disorder—Gabapentin—migraine	0.000262	0.00135	CcSEcCtD
Mefloquine—Tinnitus—Gabapentin—migraine	0.000262	0.00134	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Topiramate—migraine	0.000261	0.00134	CcSEcCtD
Mefloquine—Cardiac disorder—Gabapentin—migraine	0.00026	0.00134	CcSEcCtD
Mefloquine—Palpitations—Valproic Acid—migraine	0.00026	0.00134	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00026	0.00296	CbGpPWpGaD
Mefloquine—Renal failure—Topiramate—migraine	0.000258	0.00133	CcSEcCtD
Mefloquine—Neuropathy peripheral—Topiramate—migraine	0.000258	0.00132	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—NPS—migraine	0.000257	0.00293	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—CACNA1A—migraine	0.000256	0.00292	CbGpPWpGaD
Mefloquine—Hypertension—Valproic Acid—migraine	0.000254	0.00131	CcSEcCtD
Mefloquine—Mediastinal disorder—Gabapentin—migraine	0.000253	0.0013	CcSEcCtD
Mefloquine—BCHE—brain—migraine	0.000253	0.00443	CbGeAlD
Mefloquine—Diarrhoea—Propranolol—migraine	0.000252	0.0013	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—SLC6A4—migraine	0.000252	0.00287	CbGpPWpGaD
Mefloquine—Chills—Gabapentin—migraine	0.000252	0.00129	CcSEcCtD
Mefloquine—Arthralgia—Valproic Acid—migraine	0.000251	0.00129	CcSEcCtD
Mefloquine—Myalgia—Valproic Acid—migraine	0.000251	0.00129	CcSEcCtD
Mefloquine—Chest pain—Valproic Acid—migraine	0.000251	0.00129	CcSEcCtD
Mefloquine—Anxiety—Valproic Acid—migraine	0.00025	0.00128	CcSEcCtD
Mefloquine—Hypersensitivity—Verapamil—migraine	0.00025	0.00128	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000249	0.00128	CcSEcCtD
Mefloquine—Alopecia—Gabapentin—migraine	0.000248	0.00127	CcSEcCtD
Mefloquine—Discomfort—Valproic Acid—migraine	0.000248	0.00127	CcSEcCtD
Mefloquine—Vision blurred—Timolol—migraine	0.000247	0.00127	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000246	0.00281	CbGpPWpGaD
Mefloquine—Mental disorder—Gabapentin—migraine	0.000246	0.00126	CcSEcCtD
Mefloquine—ABCB1—cardiovascular system—migraine	0.000245	0.0043	CbGeAlD
Mefloquine—Agranulocytosis—Topiramate—migraine	0.000245	0.00126	CcSEcCtD
Mefloquine—Malnutrition—Gabapentin—migraine	0.000244	0.00125	CcSEcCtD
Mefloquine—Erythema—Gabapentin—migraine	0.000244	0.00125	CcSEcCtD
Mefloquine—Dizziness—Propranolol—migraine	0.000244	0.00125	CcSEcCtD
Mefloquine—Asthenia—Verapamil—migraine	0.000243	0.00125	CcSEcCtD
Mefloquine—Confusional state—Valproic Acid—migraine	0.000242	0.00125	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—CALCRL—migraine	0.000241	0.00274	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—RAMP1—migraine	0.000241	0.00274	CbGpPWpGaD
Mefloquine—Oedema—Valproic Acid—migraine	0.00024	0.00123	CcSEcCtD
Mefloquine—Anaphylactic shock—Valproic Acid—migraine	0.00024	0.00123	CcSEcCtD
Mefloquine—Bradycardia—Topiramate—migraine	0.00024	0.00123	CcSEcCtD
Mefloquine—Pruritus—Verapamil—migraine	0.00024	0.00123	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—HTR1D—migraine	0.000239	0.00272	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000237	0.0027	CbGpPWpGaD
Mefloquine—Nervous system disorder—Valproic Acid—migraine	0.000236	0.00121	CcSEcCtD
Mefloquine—Vertigo—Timolol—migraine	0.000236	0.00121	CcSEcCtD
Mefloquine—Thrombocytopenia—Valproic Acid—migraine	0.000235	0.00121	CcSEcCtD
Mefloquine—Syncope—Timolol—migraine	0.000235	0.00121	CcSEcCtD
Mefloquine—Hallucination—Topiramate—migraine	0.000235	0.00121	CcSEcCtD
Mefloquine—Muscle spasms—Gabapentin—migraine	0.000235	0.00121	CcSEcCtD
Mefloquine—Tachycardia—Valproic Acid—migraine	0.000235	0.00121	CcSEcCtD
Mefloquine—Vomiting—Propranolol—migraine	0.000234	0.0012	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000234	0.00267	CbGpPWpGaD
Mefloquine—Skin disorder—Valproic Acid—migraine	0.000234	0.0012	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000233	0.00266	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000233	0.00266	CbGpPWpGaD
Mefloquine—Hyperhidrosis—Valproic Acid—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—Rash—Propranolol—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—Dermatitis—Propranolol—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—Diarrhoea—Verapamil—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—Connective tissue disorder—Topiramate—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—Palpitations—Timolol—migraine	0.000232	0.00119	CcSEcCtD
Mefloquine—CYP2D6—head—migraine	0.000231	0.00405	CbGeAlD
Mefloquine—ACHE—Monoamine Transport—TNF—migraine	0.000231	0.00263	CbGpPWpGaD
Mefloquine—Loss of consciousness—Timolol—migraine	0.000231	0.00118	CcSEcCtD
Mefloquine—Vision blurred—Gabapentin—migraine	0.00023	0.00118	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000229	0.00261	CbGpPWpGaD
Mefloquine—Tremor—Gabapentin—migraine	0.000229	0.00118	CcSEcCtD
Mefloquine—Visual impairment—Topiramate—migraine	0.000227	0.00117	CcSEcCtD
Mefloquine—Ill-defined disorder—Gabapentin—migraine	0.000227	0.00116	CcSEcCtD
Mefloquine—Hypertension—Timolol—migraine	0.000226	0.00116	CcSEcCtD
Mefloquine—Hypotension—Valproic Acid—migraine	0.000225	0.00115	CcSEcCtD
Mefloquine—Agitation—Gabapentin—migraine	0.000224	0.00115	CcSEcCtD
Mefloquine—Dizziness—Verapamil—migraine	0.000224	0.00115	CcSEcCtD
Mefloquine—Chest pain—Timolol—migraine	0.000223	0.00115	CcSEcCtD
Mefloquine—Arthralgia—Timolol—migraine	0.000223	0.00115	CcSEcCtD
Mefloquine—Myalgia—Timolol—migraine	0.000223	0.00115	CcSEcCtD
Mefloquine—Erythema multiforme—Topiramate—migraine	0.000223	0.00115	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000223	0.00254	CbGpPWpGaD
Mefloquine—CYP3A4—nervous system—migraine	0.000223	0.0039	CbGeAlD
Mefloquine—Anxiety—Timolol—migraine	0.000223	0.00114	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2B—migraine	0.000222	0.00253	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000222	0.00253	CbGpPWpGaD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000222	0.00114	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—HTR7—migraine	0.000221	0.00252	CbGpPWpGaD
Mefloquine—Discomfort—Timolol—migraine	0.000221	0.00113	CcSEcCtD
Mefloquine—Eye disorder—Topiramate—migraine	0.000221	0.00113	CcSEcCtD
Mefloquine—Malaise—Gabapentin—migraine	0.00022	0.00113	CcSEcCtD
Mefloquine—Tinnitus—Topiramate—migraine	0.00022	0.00113	CcSEcCtD
Mefloquine—Vertigo—Gabapentin—migraine	0.000219	0.00113	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000219	0.00113	CcSEcCtD
Mefloquine—Flushing—Topiramate—migraine	0.000219	0.00113	CcSEcCtD
Mefloquine—Cardiac disorder—Topiramate—migraine	0.000219	0.00113	CcSEcCtD
Mefloquine—CYP2D6—nervous system—migraine	0.000219	0.00384	CbGeAlD
Mefloquine—Syncope—Gabapentin—migraine	0.000219	0.00112	CcSEcCtD
Mefloquine—Nausea—Propranolol—migraine	0.000219	0.00112	CcSEcCtD
Mefloquine—Leukopenia—Gabapentin—migraine	0.000219	0.00112	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—RAMP1—migraine	0.000219	0.00249	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CALCRL—migraine	0.000219	0.00249	CbGpPWpGaD
Mefloquine—Insomnia—Valproic Acid—migraine	0.000217	0.00112	CcSEcCtD
Mefloquine—Paraesthesia—Valproic Acid—migraine	0.000216	0.00111	CcSEcCtD
Mefloquine—Palpitations—Gabapentin—migraine	0.000216	0.00111	CcSEcCtD
Mefloquine—Confusional state—Timolol—migraine	0.000216	0.00111	CcSEcCtD
Mefloquine—Vomiting—Verapamil—migraine	0.000216	0.00111	CcSEcCtD
Mefloquine—Loss of consciousness—Gabapentin—migraine	0.000215	0.0011	CcSEcCtD
Mefloquine—Dyspnoea—Valproic Acid—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—CYP3A4—central nervous system—migraine	0.000214	0.00375	CbGeAlD
Mefloquine—Angiopathy—Topiramate—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—Anaphylactic shock—Timolol—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—Oedema—Timolol—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—Rash—Verapamil—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—Somnolence—Valproic Acid—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—Dermatitis—Verapamil—migraine	0.000214	0.0011	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000214	0.00244	CbGpPWpGaD
Mefloquine—Mediastinal disorder—Topiramate—migraine	0.000213	0.00109	CcSEcCtD
Mefloquine—Headache—Verapamil—migraine	0.000212	0.00109	CcSEcCtD
Mefloquine—Chills—Topiramate—migraine	0.000212	0.00109	CcSEcCtD
Mefloquine—Dyspepsia—Valproic Acid—migraine	0.000212	0.00109	CcSEcCtD
Mefloquine—Convulsion—Gabapentin—migraine	0.000212	0.00109	CcSEcCtD
Mefloquine—CYP2D6—central nervous system—migraine	0.000211	0.00369	CbGeAlD
Mefloquine—Hypertension—Gabapentin—migraine	0.000211	0.00108	CcSEcCtD
Mefloquine—Shock—Timolol—migraine	0.000211	0.00108	CcSEcCtD
Mefloquine—Nervous system disorder—Timolol—migraine	0.00021	0.00108	CcSEcCtD
Mefloquine—Decreased appetite—Valproic Acid—migraine	0.000209	0.00107	CcSEcCtD
Mefloquine—Alopecia—Topiramate—migraine	0.000209	0.00107	CcSEcCtD
Mefloquine—Chest pain—Gabapentin—migraine	0.000208	0.00107	CcSEcCtD
Mefloquine—Myalgia—Gabapentin—migraine	0.000208	0.00107	CcSEcCtD
Mefloquine—Arthralgia—Gabapentin—migraine	0.000208	0.00107	CcSEcCtD
Mefloquine—Skin disorder—Timolol—migraine	0.000208	0.00107	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Valproic Acid—migraine	0.000208	0.00107	CcSEcCtD
Mefloquine—Fatigue—Valproic Acid—migraine	0.000207	0.00106	CcSEcCtD
Mefloquine—Anxiety—Gabapentin—migraine	0.000207	0.00106	CcSEcCtD
Mefloquine—Hyperhidrosis—Timolol—migraine	0.000207	0.00106	CcSEcCtD
Mefloquine—Mental disorder—Topiramate—migraine	0.000207	0.00106	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000207	0.00106	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000206	0.00235	CbGpPWpGaD
Mefloquine—CYP2D6—cerebellum—migraine	0.000206	0.00361	CbGeAlD
Mefloquine—Erythema—Topiramate—migraine	0.000205	0.00106	CcSEcCtD
Mefloquine—Malnutrition—Topiramate—migraine	0.000205	0.00106	CcSEcCtD
Mefloquine—Discomfort—Gabapentin—migraine	0.000205	0.00106	CcSEcCtD
Mefloquine—Nausea—Verapamil—migraine	0.000201	0.00103	CcSEcCtD
Mefloquine—Confusional state—Gabapentin—migraine	0.000201	0.00103	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000201	0.00229	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000201	0.00229	CbGpPWpGaD
Mefloquine—Hypotension—Timolol—migraine	0.0002	0.00103	CcSEcCtD
Mefloquine—Anaphylactic shock—Gabapentin—migraine	0.000199	0.00102	CcSEcCtD
Mefloquine—Oedema—Gabapentin—migraine	0.000199	0.00102	CcSEcCtD
Mefloquine—Feeling abnormal—Valproic Acid—migraine	0.000198	0.00102	CcSEcCtD
Mefloquine—Muscle spasms—Topiramate—migraine	0.000198	0.00101	CcSEcCtD
Mefloquine—Gastrointestinal pain—Valproic Acid—migraine	0.000197	0.00101	CcSEcCtD
Mefloquine—Shock—Gabapentin—migraine	0.000196	0.00101	CcSEcCtD
Mefloquine—Nervous system disorder—Gabapentin—migraine	0.000195	0.001	CcSEcCtD
Mefloquine—Thrombocytopenia—Gabapentin—migraine	0.000195	0.001	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Timolol—migraine	0.000195	0.001	CcSEcCtD
Mefloquine—Tachycardia—Gabapentin—migraine	0.000195	0.000999	CcSEcCtD
Mefloquine—Vision blurred—Topiramate—migraine	0.000194	0.000995	CcSEcCtD
Mefloquine—Skin disorder—Gabapentin—migraine	0.000194	0.000994	CcSEcCtD
Mefloquine—Insomnia—Timolol—migraine	0.000194	0.000994	CcSEcCtD
Mefloquine—Hyperhidrosis—Gabapentin—migraine	0.000193	0.00099	CcSEcCtD
Mefloquine—Tremor—Topiramate—migraine	0.000193	0.000989	CcSEcCtD
Mefloquine—Paraesthesia—Timolol—migraine	0.000192	0.000987	CcSEcCtD
Mefloquine—Urticaria—Valproic Acid—migraine	0.000191	0.000981	CcSEcCtD
Mefloquine—Dyspnoea—Timolol—migraine	0.000191	0.00098	CcSEcCtD
Mefloquine—Ill-defined disorder—Topiramate—migraine	0.000191	0.000979	CcSEcCtD
Mefloquine—Somnolence—Timolol—migraine	0.00019	0.000977	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00019	0.00217	CbGpPWpGaD
Mefloquine—Body temperature increased—Valproic Acid—migraine	0.00019	0.000976	CcSEcCtD
Mefloquine—Abdominal pain—Valproic Acid—migraine	0.00019	0.000976	CcSEcCtD
Mefloquine—Agitation—Topiramate—migraine	0.000189	0.00097	CcSEcCtD
Mefloquine—Dyspepsia—Timolol—migraine	0.000188	0.000968	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—HTR1B—migraine	0.000188	0.00214	CbGpPWpGaD
Mefloquine—Hypotension—Gabapentin—migraine	0.000186	0.000957	CcSEcCtD
Mefloquine—Decreased appetite—Timolol—migraine	0.000186	0.000956	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—CALCRL—migraine	0.000186	0.00212	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—RAMP1—migraine	0.000186	0.00212	CbGpPWpGaD
Mefloquine—Malaise—Topiramate—migraine	0.000185	0.000952	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Timolol—migraine	0.000185	0.000949	CcSEcCtD
Mefloquine—Vertigo—Topiramate—migraine	0.000185	0.000948	CcSEcCtD
Mefloquine—Fatigue—Timolol—migraine	0.000185	0.000948	CcSEcCtD
Mefloquine—Syncope—Topiramate—migraine	0.000184	0.000946	CcSEcCtD
Mefloquine—Leukopenia—Topiramate—migraine	0.000184	0.000945	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000183	0.00209	CbGpPWpGaD
Mefloquine—Musculoskeletal discomfort—Gabapentin—migraine	0.000182	0.000933	CcSEcCtD
Mefloquine—Palpitations—Topiramate—migraine	0.000182	0.000933	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000181	0.00206	CbGpPWpGaD
Mefloquine—Loss of consciousness—Topiramate—migraine	0.000181	0.000928	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—HTR1A—migraine	0.000181	0.00206	CbGpPWpGaD
Mefloquine—Insomnia—Gabapentin—migraine	0.00018	0.000926	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00018	0.00206	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00018	0.00206	CbGpPWpGaD
Mefloquine—Paraesthesia—Gabapentin—migraine	0.000179	0.000919	CcSEcCtD
Mefloquine—Convulsion—Topiramate—migraine	0.000178	0.000914	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—NPS—migraine	0.000178	0.00203	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—TAC1—migraine	0.000178	0.00203	CbGpPWpGaD
Mefloquine—Dyspnoea—Gabapentin—migraine	0.000178	0.000913	CcSEcCtD
Mefloquine—Hypertension—Topiramate—migraine	0.000177	0.000911	CcSEcCtD
Mefloquine—Somnolence—Gabapentin—migraine	0.000177	0.00091	CcSEcCtD
Mefloquine—Hypersensitivity—Valproic Acid—migraine	0.000177	0.00091	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000177	0.00202	CbGpPWpGaD
Mefloquine—Feeling abnormal—Timolol—migraine	0.000176	0.000906	CcSEcCtD
Mefloquine—Dyspepsia—Gabapentin—migraine	0.000175	0.000901	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000175	0.002	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Timolol—migraine	0.000175	0.000899	CcSEcCtD
Mefloquine—Myalgia—Topiramate—migraine	0.000175	0.000898	CcSEcCtD
Mefloquine—Arthralgia—Topiramate—migraine	0.000175	0.000898	CcSEcCtD
Mefloquine—Chest pain—Topiramate—migraine	0.000175	0.000898	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—HTR1D—migraine	0.000175	0.00199	CbGpPWpGaD
Mefloquine—Anxiety—Topiramate—migraine	0.000174	0.000895	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—HTR2C—migraine	0.000174	0.00199	CbGpPWpGaD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000174	0.000892	CcSEcCtD
Mefloquine—Decreased appetite—Gabapentin—migraine	0.000173	0.00089	CcSEcCtD
Mefloquine—Discomfort—Topiramate—migraine	0.000173	0.000888	CcSEcCtD
Mefloquine—Asthenia—Valproic Acid—migraine	0.000173	0.000886	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Gabapentin—migraine	0.000172	0.000884	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000172	0.00196	CbGpPWpGaD
Mefloquine—Fatigue—Gabapentin—migraine	0.000172	0.000883	CcSEcCtD
Mefloquine—Pruritus—Valproic Acid—migraine	0.00017	0.000874	CcSEcCtD
Mefloquine—Urticaria—Timolol—migraine	0.00017	0.000873	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—EDNRA—migraine	0.00017	0.00193	CbGpPWpGaD
Mefloquine—Body temperature increased—Timolol—migraine	0.000169	0.000869	CcSEcCtD
Mefloquine—Abdominal pain—Timolol—migraine	0.000169	0.000869	CcSEcCtD
Mefloquine—Confusional state—Topiramate—migraine	0.000169	0.000868	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—RAMP1—migraine	0.000169	0.00192	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CALCRL—migraine	0.000169	0.00192	CbGpPWpGaD
Mefloquine—Oedema—Topiramate—migraine	0.000168	0.000861	CcSEcCtD
Mefloquine—CYP2D6—brain—migraine	0.000167	0.00293	CbGeAlD
Mefloquine—ABCB1—head—migraine	0.000166	0.00291	CbGeAlD
Mefloquine—Shock—Topiramate—migraine	0.000165	0.000847	CcSEcCtD
Mefloquine—Diarrhoea—Valproic Acid—migraine	0.000165	0.000845	CcSEcCtD
Mefloquine—Nervous system disorder—Topiramate—migraine	0.000164	0.000845	CcSEcCtD
Mefloquine—Feeling abnormal—Gabapentin—migraine	0.000164	0.000844	CcSEcCtD
Mefloquine—Thrombocytopenia—Topiramate—migraine	0.000164	0.000843	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000164	0.00187	CbGpPWpGaD
Mefloquine—Tachycardia—Topiramate—migraine	0.000164	0.000841	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CALCA—migraine	0.000163	0.00186	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Gabapentin—migraine	0.000163	0.000837	CcSEcCtD
Mefloquine—Skin disorder—Topiramate—migraine	0.000163	0.000837	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2B—migraine	0.000163	0.00185	CbGpPWpGaD
Mefloquine—Hyperhidrosis—Topiramate—migraine	0.000162	0.000833	CcSEcCtD
Mefloquine—Dizziness—Valproic Acid—migraine	0.000159	0.000817	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—HTR1D—migraine	0.000159	0.00181	CbGpPWpGaD
Mefloquine—Urticaria—Gabapentin—migraine	0.000158	0.000813	CcSEcCtD
Mefloquine—Hypersensitivity—Timolol—migraine	0.000158	0.00081	CcSEcCtD
Mefloquine—Abdominal pain—Gabapentin—migraine	0.000158	0.000809	CcSEcCtD
Mefloquine—Body temperature increased—Gabapentin—migraine	0.000158	0.000809	CcSEcCtD
Mefloquine—ABCB1—nervous system—migraine	0.000158	0.00276	CbGeAlD
Mefloquine—HBA2—Metabolism—MTHFR—migraine	0.000157	0.00179	CbGpPWpGaD
Mefloquine—Hypotension—Topiramate—migraine	0.000157	0.000805	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000155	0.00177	CbGpPWpGaD
Mefloquine—Asthenia—Timolol—migraine	0.000154	0.000789	CcSEcCtD
Mefloquine—Vomiting—Valproic Acid—migraine	0.000153	0.000785	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Topiramate—migraine	0.000153	0.000785	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—HTR7—migraine	0.000153	0.00174	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000152	0.00174	CbGpPWpGaD
Mefloquine—ABCB1—central nervous system—migraine	0.000152	0.00266	CbGeAlD
Mefloquine—Insomnia—Topiramate—migraine	0.000152	0.000779	CcSEcCtD
Mefloquine—Rash—Valproic Acid—migraine	0.000152	0.000779	CcSEcCtD
Mefloquine—Dermatitis—Valproic Acid—migraine	0.000151	0.000778	CcSEcCtD
Mefloquine—Pruritus—Timolol—migraine	0.000151	0.000778	CcSEcCtD
Mefloquine—Headache—Valproic Acid—migraine	0.000151	0.000774	CcSEcCtD
Mefloquine—Paraesthesia—Topiramate—migraine	0.000151	0.000773	CcSEcCtD
Mefloquine—Dyspnoea—Topiramate—migraine	0.00015	0.000768	CcSEcCtD
Mefloquine—Somnolence—Topiramate—migraine	0.000149	0.000766	CcSEcCtD
Mefloquine—ABCB1—cerebellum—migraine	0.000148	0.0026	CbGeAlD
Mefloquine—ADORA1—Signaling by GPCR—HTR2B—migraine	0.000148	0.00168	CbGpPWpGaD
Mefloquine—Dyspepsia—Topiramate—migraine	0.000148	0.000758	CcSEcCtD
Mefloquine—Hypersensitivity—Gabapentin—migraine	0.000147	0.000754	CcSEcCtD
Mefloquine—Diarrhoea—Timolol—migraine	0.000146	0.000752	CcSEcCtD
Mefloquine—Decreased appetite—Topiramate—migraine	0.000146	0.000749	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Topiramate—migraine	0.000145	0.000744	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—HTR1B—migraine	0.000145	0.00165	CbGpPWpGaD
Mefloquine—Fatigue—Topiramate—migraine	0.000145	0.000743	CcSEcCtD
Mefloquine—Asthenia—Gabapentin—migraine	0.000143	0.000735	CcSEcCtD
Mefloquine—Nausea—Valproic Acid—migraine	0.000143	0.000734	CcSEcCtD
Mefloquine—Dizziness—Timolol—migraine	0.000142	0.000727	CcSEcCtD
Mefloquine—Pruritus—Gabapentin—migraine	0.000141	0.000724	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00014	0.0016	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR1A—migraine	0.000139	0.00159	CbGpPWpGaD
Mefloquine—Feeling abnormal—Topiramate—migraine	0.000138	0.00071	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—TAC1—migraine	0.000137	0.00156	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—NPS—migraine	0.000137	0.00156	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Topiramate—migraine	0.000137	0.000704	CcSEcCtD
Mefloquine—Diarrhoea—Gabapentin—migraine	0.000136	0.0007	CcSEcCtD
Mefloquine—Vomiting—Timolol—migraine	0.000136	0.000699	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR1D—migraine	0.000135	0.00154	CbGpPWpGaD
Mefloquine—Rash—Timolol—migraine	0.000135	0.000693	CcSEcCtD
Mefloquine—Dermatitis—Timolol—migraine	0.000135	0.000693	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2C—migraine	0.000135	0.00153	CbGpPWpGaD
Mefloquine—Headache—Timolol—migraine	0.000134	0.000689	CcSEcCtD
Mefloquine—Urticaria—Topiramate—migraine	0.000133	0.000684	CcSEcCtD
Mefloquine—Abdominal pain—Topiramate—migraine	0.000133	0.000681	CcSEcCtD
Mefloquine—Body temperature increased—Topiramate—migraine	0.000133	0.000681	CcSEcCtD
Mefloquine—Dizziness—Gabapentin—migraine	0.000132	0.000677	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—EDNRA—migraine	0.000131	0.00149	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RAMP1—migraine	0.000129	0.00147	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CALCRL—migraine	0.000129	0.00147	CbGpPWpGaD
Mefloquine—Nausea—Timolol—migraine	0.000127	0.000653	CcSEcCtD
Mefloquine—Vomiting—Gabapentin—migraine	0.000127	0.000651	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—ESR1—migraine	0.000127	0.00144	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000127	0.00144	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CALCA—migraine	0.000126	0.00144	CbGpPWpGaD
Mefloquine—Rash—Gabapentin—migraine	0.000126	0.000645	CcSEcCtD
Mefloquine—Dermatitis—Gabapentin—migraine	0.000126	0.000645	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2B—migraine	0.000126	0.00143	CbGpPWpGaD
Mefloquine—Headache—Gabapentin—migraine	0.000125	0.000641	CcSEcCtD
Mefloquine—Hypersensitivity—Topiramate—migraine	0.000124	0.000635	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—HTR1D—migraine	0.000123	0.0014	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	0.000122	0.0014	CbGpPWpGaD
Mefloquine—ABCB1—brain—migraine	0.00012	0.00211	CbGeAlD
Mefloquine—Asthenia—Topiramate—migraine	0.00012	0.000618	CcSEcCtD
Mefloquine—HBA1—Metabolism—MTHFR—migraine	0.000119	0.00135	CbGpPWpGaD
Mefloquine—Pruritus—Topiramate—migraine	0.000119	0.000609	CcSEcCtD
Mefloquine—Nausea—Gabapentin—migraine	0.000118	0.000608	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—HTR7—migraine	0.000118	0.00134	CbGpPWpGaD
Mefloquine—Diarrhoea—Topiramate—migraine	0.000115	0.000589	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000114	0.0013	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2B—migraine	0.000114	0.0013	CbGpPWpGaD
Mefloquine—Dizziness—Topiramate—migraine	0.000111	0.00057	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000108	0.00124	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—HTR2A—migraine	0.000107	0.00122	CbGpPWpGaD
Mefloquine—Vomiting—Topiramate—migraine	0.000107	0.000548	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—HTR1B—migraine	0.000106	0.00121	CbGpPWpGaD
Mefloquine—Rash—Topiramate—migraine	0.000106	0.000543	CcSEcCtD
Mefloquine—Dermatitis—Topiramate—migraine	0.000106	0.000543	CcSEcCtD
Mefloquine—Headache—Topiramate—migraine	0.000105	0.00054	CcSEcCtD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	0.000105	0.00119	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR1A—migraine	0.000102	0.00116	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TAC1—migraine	0.0001	0.00115	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—NPS—migraine	0.0001	0.00115	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CALCRL—migraine	9.97e-05	0.00114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RAMP1—migraine	9.97e-05	0.00114	CbGpPWpGaD
Mefloquine—Nausea—Topiramate—migraine	9.96e-05	0.000512	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2C—migraine	9.85e-05	0.00112	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR1B—migraine	9.62e-05	0.0011	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—EDNRA—migraine	9.58e-05	0.00109	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR1D—migraine	9.38e-05	0.00107	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	9.28e-05	0.00106	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	9.28e-05	0.00106	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR1A—migraine	9.26e-05	0.00106	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CALCA—migraine	9.23e-05	0.00105	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TAC1—migraine	9.12e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NPS—migraine	9.12e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2C—migraine	8.95e-05	0.00102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2B—migraine	8.72e-05	0.000995	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EDNRA—migraine	8.7e-05	0.000992	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR7—migraine	8.63e-05	0.000984	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CALCA—migraine	8.38e-05	0.000955	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—HTR2A—migraine	8.26e-05	0.000941	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR1B—migraine	8.18e-05	0.000933	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	7.89e-05	0.000899	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR1A—migraine	7.88e-05	0.000898	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR7—migraine	7.84e-05	0.000893	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—NPS—migraine	7.76e-05	0.000884	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TAC1—migraine	7.76e-05	0.000884	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LRP1—migraine	7.68e-05	0.000876	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2C—migraine	7.61e-05	0.000867	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR1B—migraine	7.43e-05	0.000847	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—EDNRA—migraine	7.4e-05	0.000844	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR1D—migraine	7.24e-05	0.000826	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CACNA1A—migraine	7.22e-05	0.000823	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR1A—migraine	7.15e-05	0.000815	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CALCA—migraine	7.12e-05	0.000812	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TAC1—migraine	7.04e-05	0.000803	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NPS—migraine	7.04e-05	0.000803	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ACE—migraine	6.94e-05	0.000792	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2C—migraine	6.91e-05	0.000788	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2B—migraine	6.74e-05	0.000768	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EDNRA—migraine	6.72e-05	0.000766	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR7—migraine	6.66e-05	0.00076	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CACNA1A—migraine	6.63e-05	0.000756	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	6.62e-05	0.000755	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CALCA—migraine	6.47e-05	0.000737	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CACNA1A—migraine	6.44e-05	0.000734	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ACE—migraine	6.19e-05	0.000706	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR7—migraine	6.05e-05	0.00069	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—HTR2A—migraine	6.04e-05	0.000689	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LRP1—migraine	5.93e-05	0.000676	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH4—migraine	5.89e-05	0.000672	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR1B—migraine	5.68e-05	0.000648	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.53e-05	0.00063	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HTR2A—migraine	5.49e-05	0.000626	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR1A—migraine	5.47e-05	0.000624	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NPS—migraine	5.39e-05	0.000614	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TAC1—migraine	5.39e-05	0.000614	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PGR—migraine	5.39e-05	0.000614	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2C—migraine	5.29e-05	0.000603	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EDNRA—migraine	5.14e-05	0.000586	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH3—migraine	5.01e-05	0.000571	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	4.97e-05	0.000566	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CALCA—migraine	4.95e-05	0.000564	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—migraine	4.88e-05	0.000556	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—HTR2A—migraine	4.67e-05	0.000532	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR7—migraine	4.63e-05	0.000528	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH4—migraine	4.55e-05	0.000519	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR1B—migraine	4.39e-05	0.0005	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HTR2A—migraine	4.24e-05	0.000483	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR1A—migraine	4.23e-05	0.000482	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TAC1—migraine	4.16e-05	0.000474	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NPS—migraine	4.16e-05	0.000474	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PGR—migraine	4.16e-05	0.000474	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2C—migraine	4.08e-05	0.000465	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFBR2—migraine	3.99e-05	0.000455	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDNRA—migraine	3.97e-05	0.000453	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH3—migraine	3.87e-05	0.000441	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CALCA—migraine	3.82e-05	0.000436	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR7—migraine	3.57e-05	0.000407	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HTR2A—migraine	3.24e-05	0.00037	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CACNA1A—migraine	3.14e-05	0.000358	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFBR2—migraine	3.08e-05	0.000351	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CACNA1A—migraine	2.96e-05	0.000338	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ESR1—migraine	2.88e-05	0.000328	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HTR2A—migraine	2.5e-05	0.000285	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.41e-05	0.000274	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MTHFR—migraine	2.39e-05	0.000272	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ESR1—migraine	2.22e-05	0.000253	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—migraine	2.19e-05	0.00025	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—migraine	2.13e-05	0.000243	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CACNA1A—migraine	1.94e-05	0.000221	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—migraine	1.04e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—migraine	9.79e-06	0.000112	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—migraine	6.4e-06	7.3e-05	CbGpPWpGaD
